Advertisement

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Improved Turnaround Times | Median time to first decision: 12 days

Research ArticleBrain

Qualitative versus Quantitative Assessment of Cerebrovascular Reactivity to Acetazolamide Using iodine-123-N-Isopropyl-p-Iodoamphetamine SPECT in Patients with Unilateral Major Cerebral Artery Occlusive Disease

Kuniaki Ogasawara, Taku Okuguchi, Masayuki Sasoh, Masakazu Kobayashi, Hirotsugu Yukawa, Kazunori Terasaki, Takashi Inoue and Akira Ogawa
American Journal of Neuroradiology June 2003, 24 (6) 1090-1095;

References

  1. ↵
    Burt RW, Witt RM, Cikrit DF, Reddy RV. Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT. Radiology 1992;182:461–466
    PubMedWeb of Science
  2. Hoshi H, Ohnishi T, Jinnouchi S, et al. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. J Nucl Med 1994;35:44–50
    Abstract/FREE Full Text
  3. Soricelli A, Postiglione A, Cuocolo A, et al. Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease: a comparison with acetazolamide. Stroke 1995;26:1572–1576
    Abstract/FREE Full Text
  4. Ohnishi T, Yano T, Nakano S, et al. Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease. J Nucl Med 1997;38:1463–1467
    Abstract/FREE Full Text
  5. Ozgur HT, Kent Walsh T, Masaryk A, et al. Correlation of cerebrovascular reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra- or extracranial arterial stenosis. AJNR Am J Neuroradiol 2001;22:928–936
    Abstract/FREE Full Text
  6. Kim JS, Moon DH, Kim GE, et al. Acetazolamide stress brain-perfusion SPECT predicts the need for carotid shunting during carotid endarterectomy. J Nucl Med 2000;41:1836–1841
    Abstract/FREE Full Text
  7. Marti-Fabregas JA, Catafau AM, Mari C, et al. Cerebral perfusion and haemodynamics measured by SPECT in symptom-free patients with transient ischaemic attack: clinical implications. Eur J Nucl Med 2001;28:1828–1835
    PubMed
  8. Kim JH, Lee SJ, Shin T, et al. Correlative assessment of hemodynamic parameters obtained with T2*-weighted perfusion MR imaging and SPECT in symptomatic carotid artery occlusion. AJNR Am J Neuroradiol 2000;21:1450–1456
    Abstract/FREE Full Text
  9. Cao B, Hasegawa Y, Yokota C, et al. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease. J Nucl Med 1998;39:1348–1353
    Abstract/FREE Full Text
  10. Isaka Y, Nagano K, Narita M, Ashida K, Imaizumi M. High signal intensity on T2-weighted magnetic resonance imaging and cerebral hemodynamic reserve in carotid occlusive disease. Stroke 1997;28:354–357
    Abstract/FREE Full Text
  11. Hwang TL, Saenz A, Farrell JJ, Brannon WL. Brain SPECT with dipyridamole stress to evaluate cerebral blood flow reserve in carotid artery disease. J Nucl Med 1996;37:1595–1599
    Abstract/FREE Full Text
  12. Knapp WH, Dannenberg C, Marschall B, et al. Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function. Eur J Nucl Med 1996;23:878–888
    CrossRefPubMed
  13. Laloux P, Jamart J, Meurisse H, De Coster P, Laterre C. Persisting perfusion defect in transient ischemic attacks: a new clinically useful subgroup? Stroke 1996;27:425–430
    Abstract/FREE Full Text
  14. ↵
    Touho H, Karasawa J, Ohnishi H. Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease. Stroke 1996;27:282–289
    Abstract/FREE Full Text
  15. ↵
    Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110–2116
    Abstract/FREE Full Text
  16. ↵
    Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 2002;33:1857–1862
    Abstract/FREE Full Text
  17. ↵
    Yokota C, Hasegawa Y, Minematsu K, Yamaguchi T. Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive diseases. Stroke 1998;29:640–644
    Abstract/FREE Full Text
  18. ↵
    Yonas H, Pindzola RR. Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive diseases. Stroke 1998;29:1742–1744
    FREE Full Text
  19. ↵
    Yonas H, Pindzola RR, Meltzer CC, Sasser H. Qualitative versus quantitative assessment of cerebrovascular reserves. Neurosurgery 1998;42:1005–1012
    CrossRefPubMedWeb of Science
  20. ↵
    Iida H, Itoh H, Nakazawa M, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 1994;35:2019–2030
    Abstract/FREE Full Text
  21. ↵
    Iida H, Itoh H, Bloomfield PM, et al. A clinical method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling. Eur J Nucl Med 1994;21:1072–1084
    PubMed
  22. ↵
    Ogasawara K, Ito H, Sasoh M, et al. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using iodine-123-IMP autoradiography with SPECT: validation study using oxygen-15-water with PET J Nucl Med 2003;44:520–525.
    Abstract/FREE Full Text
  23. ↵
    Ogura T, Takikawa S, Saito H, Nakazawa M, Shidahara M, Iida H. Validation and optimization of the use of standardized arterial input function in N-isopropyl-p[123I]iodoamphetamine cerebral blood flow SPECT. Kaku Igaku (Jpn J Nucl Med) 1999;36:879–890
    PubMed
  24. ↵
    Hatazawa J, Iida H, Shimosegawa E, Sato T, Murakami M, Miura Y. Regional cerebral blood flow measurement with iodine-123-IMP autoradiography: normal values, reproducibility and sensitivity to hypoperfusion. J Nucl Med 1997;38:1102–1108
    Abstract/FREE Full Text
  25. ↵
    Toyoda H, Nishizawa S, Shiozaki T, Ueno M, Konishi J. A simplified double-injection method to quantify cerebral blood flow and vascular reserve using iodine-123 IMP-SPECT. Ann Nucl Med 2002;16:127–135
    PubMed
  26. ↵
    Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238–1248
    Abstract/FREE Full Text
  27. ↵
    Cohen J A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:27–46
  28. ↵
    Yamauchi H, Fukuyama H, Kimura J, Konishi J, Kameyama M. Hemodynamics in internal carotid artery occlusion examined by positron emission tomography. Stroke 1990;21:1400–1406
    Abstract/FREE Full Text
  29. ↵
    Yamauchi H, Fukuyama H, Nagahama Y, et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 1999;40:1992–1998
    Abstract/FREE Full Text
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Cite this article
0 Responses
Respond to this article
Bookmark this article
Qualitative versus Quantitative Assessment of Cerebrovascular Reactivity to Acetazolamide Using iodine-123-N-Isopropyl-p-Iodoamphetamine SPECT in Patients with Unilateral Major Cerebral Artery Occlusive Disease
Kuniaki Ogasawara, Taku Okuguchi, Masayuki Sasoh, Masakazu Kobayashi, Hirotsugu Yukawa, Kazunori Terasaki, Takashi Inoue, Akira Ogawa
American Journal of Neuroradiology Jun 2003, 24 (6) 1090-1095;
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement